Vps34p differentially regulates endocytosis from the apical and basolateral domains in polarized hepatic cells

Pamela L. Tuma, Lydia K. Nyasae, Jonathan M. Backer, Ann L. Hubbard

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Using a microinjection approach to study apical plasma membrane protein trafficking in hepatic cells, we found that specific inhibition of Vps34p, a class III phosphoinositide 3 (PI-3) kinase, nearly perfectly recapitulated the defects we reported for wortmannin-treated cells (Tuma, P.L., C.M. Finnegan, J.-H Yi, and A.L. Hubbard. 1999. J. Cell Biol. 145:1089-1102). Both wortmannin and injection of inhibitory Vps34p antibodies led to the accumulation of resident apical proteins in enlarged prelysosomes, whereas transcytosing apical proteins and recycling basolateral receptors transiently accumulated in basolateral early endosomes. To understand how the Vps34p catalytic product, PI(3)P, was differentially regulating endocytosis from the two domains, we examined the PI(3)P binding protein early endosomal antigen 1 (EEA1). We determined that EEA1 distributed to two biochemically distinct endosomal populations: basolateral early endosomes and subapical endosomes. Both contained rab5, although the latter also contained late endosomal markers but was distinct from the transcytotic intermediate, the subapical compartment. When PI(3)P was depleted, EEA1 dissociated from basolateral endosomes, whereas it remained on subapical endosomes. From these results, we conclude that PI(3)P, via EEA1, regulates early steps in endocytosis from the basolateral surface in polarized WIF-B cells. However, PI(3)P must use different machinery in its regulation of the apical endocytic pathway, since later steps are affected by Vps34p inhibition.

Original languageEnglish (US)
Pages (from-to)1197-1208
Number of pages12
JournalJournal of Cell Biology
Volume154
Issue number6
DOIs
StatePublished - Sep 17 2001

Fingerprint

Endosomes
Endocytosis
Hepatocytes
Antigens
1-Phosphatidylinositol 4-Kinase
Microinjections
Recycling
Protein Transport
Blood Proteins
Carrier Proteins
Membrane Proteins
Proteins
B-Lymphocytes
Cell Membrane
Injections
Antibodies
Population
wortmannin

Keywords

  • Endocytosis
  • Hepatocytes
  • Phosphoinositides
  • Polarity
  • Transcytosis

ASJC Scopus subject areas

  • Cell Biology

Cite this

Vps34p differentially regulates endocytosis from the apical and basolateral domains in polarized hepatic cells. / Tuma, Pamela L.; Nyasae, Lydia K.; Backer, Jonathan M.; Hubbard, Ann L.

In: Journal of Cell Biology, Vol. 154, No. 6, 17.09.2001, p. 1197-1208.

Research output: Contribution to journalArticle

@article{7b999eb13e4d46c698d491eb53d8e38a,
title = "Vps34p differentially regulates endocytosis from the apical and basolateral domains in polarized hepatic cells",
abstract = "Using a microinjection approach to study apical plasma membrane protein trafficking in hepatic cells, we found that specific inhibition of Vps34p, a class III phosphoinositide 3 (PI-3) kinase, nearly perfectly recapitulated the defects we reported for wortmannin-treated cells (Tuma, P.L., C.M. Finnegan, J.-H Yi, and A.L. Hubbard. 1999. J. Cell Biol. 145:1089-1102). Both wortmannin and injection of inhibitory Vps34p antibodies led to the accumulation of resident apical proteins in enlarged prelysosomes, whereas transcytosing apical proteins and recycling basolateral receptors transiently accumulated in basolateral early endosomes. To understand how the Vps34p catalytic product, PI(3)P, was differentially regulating endocytosis from the two domains, we examined the PI(3)P binding protein early endosomal antigen 1 (EEA1). We determined that EEA1 distributed to two biochemically distinct endosomal populations: basolateral early endosomes and subapical endosomes. Both contained rab5, although the latter also contained late endosomal markers but was distinct from the transcytotic intermediate, the subapical compartment. When PI(3)P was depleted, EEA1 dissociated from basolateral endosomes, whereas it remained on subapical endosomes. From these results, we conclude that PI(3)P, via EEA1, regulates early steps in endocytosis from the basolateral surface in polarized WIF-B cells. However, PI(3)P must use different machinery in its regulation of the apical endocytic pathway, since later steps are affected by Vps34p inhibition.",
keywords = "Endocytosis, Hepatocytes, Phosphoinositides, Polarity, Transcytosis",
author = "Tuma, {Pamela L.} and Nyasae, {Lydia K.} and Backer, {Jonathan M.} and Hubbard, {Ann L.}",
year = "2001",
month = "9",
day = "17",
doi = "10.1083/jcb.200105138",
language = "English (US)",
volume = "154",
pages = "1197--1208",
journal = "Journal of Cell Biology",
issn = "0021-9525",
publisher = "Rockefeller University Press",
number = "6",

}

TY - JOUR

T1 - Vps34p differentially regulates endocytosis from the apical and basolateral domains in polarized hepatic cells

AU - Tuma, Pamela L.

AU - Nyasae, Lydia K.

AU - Backer, Jonathan M.

AU - Hubbard, Ann L.

PY - 2001/9/17

Y1 - 2001/9/17

N2 - Using a microinjection approach to study apical plasma membrane protein trafficking in hepatic cells, we found that specific inhibition of Vps34p, a class III phosphoinositide 3 (PI-3) kinase, nearly perfectly recapitulated the defects we reported for wortmannin-treated cells (Tuma, P.L., C.M. Finnegan, J.-H Yi, and A.L. Hubbard. 1999. J. Cell Biol. 145:1089-1102). Both wortmannin and injection of inhibitory Vps34p antibodies led to the accumulation of resident apical proteins in enlarged prelysosomes, whereas transcytosing apical proteins and recycling basolateral receptors transiently accumulated in basolateral early endosomes. To understand how the Vps34p catalytic product, PI(3)P, was differentially regulating endocytosis from the two domains, we examined the PI(3)P binding protein early endosomal antigen 1 (EEA1). We determined that EEA1 distributed to two biochemically distinct endosomal populations: basolateral early endosomes and subapical endosomes. Both contained rab5, although the latter also contained late endosomal markers but was distinct from the transcytotic intermediate, the subapical compartment. When PI(3)P was depleted, EEA1 dissociated from basolateral endosomes, whereas it remained on subapical endosomes. From these results, we conclude that PI(3)P, via EEA1, regulates early steps in endocytosis from the basolateral surface in polarized WIF-B cells. However, PI(3)P must use different machinery in its regulation of the apical endocytic pathway, since later steps are affected by Vps34p inhibition.

AB - Using a microinjection approach to study apical plasma membrane protein trafficking in hepatic cells, we found that specific inhibition of Vps34p, a class III phosphoinositide 3 (PI-3) kinase, nearly perfectly recapitulated the defects we reported for wortmannin-treated cells (Tuma, P.L., C.M. Finnegan, J.-H Yi, and A.L. Hubbard. 1999. J. Cell Biol. 145:1089-1102). Both wortmannin and injection of inhibitory Vps34p antibodies led to the accumulation of resident apical proteins in enlarged prelysosomes, whereas transcytosing apical proteins and recycling basolateral receptors transiently accumulated in basolateral early endosomes. To understand how the Vps34p catalytic product, PI(3)P, was differentially regulating endocytosis from the two domains, we examined the PI(3)P binding protein early endosomal antigen 1 (EEA1). We determined that EEA1 distributed to two biochemically distinct endosomal populations: basolateral early endosomes and subapical endosomes. Both contained rab5, although the latter also contained late endosomal markers but was distinct from the transcytotic intermediate, the subapical compartment. When PI(3)P was depleted, EEA1 dissociated from basolateral endosomes, whereas it remained on subapical endosomes. From these results, we conclude that PI(3)P, via EEA1, regulates early steps in endocytosis from the basolateral surface in polarized WIF-B cells. However, PI(3)P must use different machinery in its regulation of the apical endocytic pathway, since later steps are affected by Vps34p inhibition.

KW - Endocytosis

KW - Hepatocytes

KW - Phosphoinositides

KW - Polarity

KW - Transcytosis

UR - http://www.scopus.com/inward/record.url?scp=0035904227&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035904227&partnerID=8YFLogxK

U2 - 10.1083/jcb.200105138

DO - 10.1083/jcb.200105138

M3 - Article

C2 - 11564757

AN - SCOPUS:0035904227

VL - 154

SP - 1197

EP - 1208

JO - Journal of Cell Biology

JF - Journal of Cell Biology

SN - 0021-9525

IS - 6

ER -